SCHEMBL21282983

SCHEMBL21282983

Cc1cc2c(nc1C(C)C)NC(C[C@@H](C)c1nc3c(cc1C)OCCN3)CN2

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21281642 0.80 ALDH1A1 (0.38)
SCHEMBL21282897 0.75
SCHEMBL21282896 0.73
SCHEMBL21281707 0.69 GRM5 (0.36)
SCHEMBL21281643 0.67 UHRF1 (0.35)
SCHEMBL20153298 0.64 ALDH1A1 (0.42)
SCHEMBL21284301 0.63
SCHEMBL21281639 0.62 ALDH1A1 (0.38)
SCHEMBL21605829 0.62 ALDH1A1 (0.40)
SCHEMBL21281649 0.61 UHRF1 (0.46)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210246136-A1 CYCLOBUTANES- AND AZETIDINE-CONTAINING MONO AND SPIROCYCLIC COMPOUNDS AS ALPHA V INTEGRIN INHIBITORS BRISTOL MYERS SQUIBB CO (US) 2021-08-12 US disclosed
US-10745384-B2 Indazole derivatives as αv integrin antagonists BRISTOL-MYERS SQUIBB COMPANY (US) 2020-08-18 US disclosed
US-20190256496-A1 INDAZOLE DERIVATIVES AS ALPHA V INTEGRIN ANTAGONISTS BRISTOL MYERS SQUIBB CO (US) 2019-08-22 US disclosed